Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ALKEM LABORATORIES. For more details, see the ALKEM LABORATORIES quarterly results and ALKEM LABORATORIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.7 |
No. of shares | m | 119.57 |
1 Week | % | -4.7 |
1 Month | % | -7.6 |
1 Year | % | 39.8 |
52 week H/L | Rs | 5,519.1/3,211.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALKEM LABORATORIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,265 | 2,720 | 3,150 | 4,068 | 3,625 | |
Low | Rs | 1,693 | 1,660 | 2,224 | 2,671 | 2,835 | |
Sales per share (Unadj.) | Rs | 615.3 | 697.9 | 741.4 | 889.4 | 970.1 | |
Earnings per share (Unadj.) | Rs | 64.7 | 96.1 | 135.3 | 140.5 | 84.2 | |
Diluted earnings per share | Rs | 64.7 | 96.1 | 135.3 | 140.5 | 84.2 | |
Cash flow per share (Unadj.) | Rs | 80.9 | 117.3 | 158.3 | 166.0 | 110.2 | |
Dividends per share (Unadj.) | Rs | 16.00 | 25.00 | 30.00 | 34.00 | 50.00 | |
Adj. dividends per share | Rs | 16.00 | 25.00 | 30.00 | 34.00 | 50.00 | |
Avg Dividend yield | % | 0.8 | 1.1 | 1.1 | 1.0 | 1.5 | |
Book value per share (Unadj.) | Rs | 454.8 | 515.1 | 616.8 | 722.4 | 756.4 | |
Adj. book value per share | Rs | 454.8 | 515.1 | 616.9 | 722.4 | 756.5 | |
Shares outstanding (eoy) | m | 119.57 | 119.57 | 119.57 | 119.57 | 119.57 | |
Price / Sales ratio | x | 3.2 | 3.1 | 3.6 | 3.8 | 3.3 | |
Avg P/E ratio | x | 30.6 | 22.8 | 19.9 | 24.0 | 38.4 | |
P/CF ratio (eoy) | x | 24.5 | 18.7 | 17.0 | 20.3 | 29.3 | |
Price / Book Value ratio | x | 4.4 | 4.3 | 4.4 | 4.7 | 4.3 | |
Dividend payout | % | 24.7 | 26.0 | 22.2 | 24.2 | 59.4 | |
Avg Mkt Cap | Rs m | 236,619 | 261,868 | 321,244 | 402,868 | 386,207 | |
Total wages/salary | Rs m | 13,625 | 15,055 | 16,210 | 19,627 | 21,314 |
ALKEM LABORATORIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 73,572 | 83,444 | 88,650 | 106,342 | 115,993 | |
Other income | Rs m | 877 | 1,042 | 2,332 | 1,627 | 2,161 | |
Total revenues | Rs m | 74,449 | 84,486 | 90,982 | 107,968 | 118,153 | |
Gross profit | Rs m | 11,148 | 14,734 | 19,424 | 20,380 | 15,065 | |
Depreciation | Rs m | 1,932 | 2,528 | 2,746 | 3,040 | 3,104 | |
Interest | Rs m | 546 | 651 | 589 | 524 | 1,074 | |
Profit before tax | Rs m | 9,547 | 12,598 | 18,421 | 18,443 | 13,048 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,810 | 1,105 | 2,243 | 1,640 | 2,980 | |
Profit after tax | Rs m | 7,736 | 11,493 | 16,178 | 16,803 | 10,068 | |
Gross profit margin | % | 15.2 | 17.7 | 21.9 | 19.2 | 13.0 | |
Effective tax rate | % | 19.0 | 8.8 | 12.2 | 8.9 | 22.8 | |
Net profit margin | % | 10.5 | 13.8 | 18.2 | 15.8 | 8.7 |
ALKEM LABORATORIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 42,044 | 54,876 | 69,233 | 84,337 | 86,064 | |
Current liabilities | Rs m | 22,175 | 32,446 | 36,041 | 48,053 | 37,071 | |
Net working cap to sales | % | 27.0 | 26.9 | 37.4 | 34.1 | 42.2 | |
Current ratio | x | 1.9 | 1.7 | 1.9 | 1.8 | 2.3 | |
Inventory Days | Days | 24 | 18 | 20 | 42 | 33 | |
Debtors Days | Days | 62 | 72 | 66 | 65 | 67 | |
Net fixed assets | Rs m | 32,844 | 35,073 | 34,825 | 43,245 | 37,245 | |
Share capital | Rs m | 239 | 239 | 239 | 239 | 239 | |
"Free" reserves | Rs m | 54,139 | 61,354 | 73,517 | 86,134 | 90,208 | |
Net worth | Rs m | 54,378 | 61,593 | 73,756 | 86,373 | 90,447 | |
Long term debt | Rs m | 2,313 | 739 | 279 | 94 | 0 | |
Total assets | Rs m | 75,006 | 90,130 | 104,114 | 127,599 | 124,541 | |
Interest coverage | x | 18.5 | 20.4 | 32.3 | 36.2 | 13.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.0 | 0.9 | 0.9 | 0.8 | 0.9 | |
Return on assets | % | 11.0 | 13.5 | 16.1 | 13.6 | 8.9 | |
Return on equity | % | 14.2 | 18.7 | 21.9 | 19.5 | 11.1 | |
Return on capital | % | 17.8 | 21.3 | 25.7 | 21.9 | 15.6 | |
Exports to sales | % | 16.6 | 19.2 | 22.1 | 18.7 | 14.6 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 12,238 | 16,061 | 19,555 | 19,924 | 16,916 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 12,238 | 16,061 | 19,555 | 19,924 | 16,916 | |
Fx outflow | Rs m | 2,105 | 2,483 | 2,467 | 3,911 | 4,190 | |
Net fx | Rs m | 10,133 | 13,578 | 17,088 | 16,013 | 12,727 |
ALKEM LABORATORIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 7,797 | 5,851 | 12,649 | 11,110 | 16,825 | |
From Investments | Rs m | -3,164 | -7,414 | -9,985 | -14,351 | 1,128 | |
From Financial Activity | Rs m | -3,789 | 792 | -2,718 | 3,796 | -17,608 | |
Net Cashflow | Rs m | 823 | -731 | -17 | 580 | 416 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Basudeo N Singh | COMP SEC: Manish Narang | YEAR OF INC: 1973 | BSE CODE: 539523 | FV (Rs): 2 | DIV YIELD (%): 1.1 |
Read: ALKEM LABORATORIES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ALKEM LABORATORIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.